Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD
While poor inhaler technique in asthma and chronic obstructive pulmonary disease (COPD) can compromise the effectiveness of inhaled medications, identifying and quantifying these errors may suggest ways to improve inhalation technique and patient outcomes. The objective of this international, multic...
Main Authors: | Jordi Giner, Marta Villarnovo Cerrillo, Jaime Aboín Sierra, Laura Casas Herrero, Oliver Patino, Vicente Plaza |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | European Clinical Respiratory Journal |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20018525.2020.1833411 |
Similar Items
-
Effects of symbicort turbuhaler combined with tiotropium bromide on serum PCT, TIMP-1, MMP-9, IFN- γ , arterial blood gases and pulmonary function in patients with AECOPD
by: Yan Zhang, et al.
Published: (2017-10-01) -
Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden
by: Christer Janson, et al.
Published: (2019-01-01) -
Emitted dose estimates from Seretide® Diskus® and Symbicort® Turbuhaler® following inhalation by severe asthmatics
by: Assi, Khaled H., et al.
Published: (2009) -
Utility and effectiveness of Symbicort® Turbuhaler® (oral inhalation containing budesonide and formoterol) in a patient with severe asthma after permanent tracheostomy
by: Kohhei Maeda, et al.
Published: (2018-09-01) -
Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers
by: Per Rönmark, et al.
Published: (2018-01-01)